What Neocidol Treats: Main Uses and Benefits

Neocidol is commonly used in veterinary medicine for managing external parasitic infestations in livestock, including cattle, sheep, and goats, where its use is aligned with control in target species.

The medication is applied in addressing conditions characterized by periods of heightened symptoms caused by acarids, notably mange and scab, as well as common insect infestations from lice, ticks, and fleas. This action is relevant for easing symptoms that cluster into patterns of severe skin irritation and pruritus (itching).

It may assist in managing the external parasite load across the animal population, which supports general well-being and assists with maintaining functional stability during phases when symptoms become more noticeable. It may be considered relevant for managing parasitic burdens in a strategic manner.

---

Quick Fact: Support for Dermatological Symptoms
Commonly Used For: Managing scaly skin, lesions, and restlessness caused by mites and ticks in livestock.
Core Benefit: Provides support that helps ease the overall symptom burden, and assists with maintaining functional stability.

Official Eligibility and Contraindications

Neocidol, which contains the organophosphate Diazinon, is not a human medicine. It is regulated as a highly toxic pesticide for veterinary, agricultural, or pest control use. Therefore, eligibility rules focus strictly on exposure control and handling restrictions defined by government health and environmental agencies (e.g., US EPA, international bodies).

---

Populations Who Must NOT Use or Be Exposed

Classification	Restriction and Exclusion Criteria
Absolute Contraindication	The product must never be used on humans.
Unsafe Exposure	Unprotected individuals (those not wearing required Personal Protective Equipment) are prohibited from handling or entering the area during application.
Vulnerable Groups	Children and the general public must not enter the treated area until the spray has fully dried and the official Restricted Entry Interval (REI) has passed.

---

Populations with Restricted or Conditional Use

Classification	Eligibility Condition
Handlers	Use is restricted to Certified Applicators or persons under their direct supervision, contingent upon strict adherence to the Worker Protection Standard and use of mandatory PPE.
Reproductive Health	Pregnant individuals and those of reproductive age must exercise extreme caution due to documented fetal and reproductive toxicity hazards, mandating full compliance with protective measures.

The official eligibility profile is defined by who is authorized to handle the hazardous substance safely, not by a therapeutic indication.

Interactions with other medicines and products

Regulatory documentation defines strict interaction patterns for the active ingredient, Dimpylate, driven by its classification as an organophosphorus compound. These interactions are primarily focused on pharmacodynamic potentiation and mandatory administration restrictions.

---

Official Regulatory Prohibitions and Timing Rules

Classification	Restriction or Requirement
Contraindicated Combinations	Co-administration with other organophosphorus compounds is strictly prohibited due to the high risk of potentiation leading to cumulative toxicity.
Other Insecticides	The co-administration of other insecticides is prohibited and requires a mandatory 7-day separation window after discontinuing Dimpylate use.
Incompatible Medicines	Combination with other medicines which are not compatible with organophosphorus compounds is prohibited as defined in regulatory documentation.

---

Documented Exposure-Altering Interactions

The interaction profile recognizes the risk of additive effects with other pest control agents, including specific carbamates and pyrethroids. Furthermore, the substance Phenobarbital is documented to cause a pharmacokinetic interaction by inducing hepatic degradation of the organophosphate. This process is officially noted to increase clearance and thereby alter the systemic exposure of Dimpylate. The overall interaction structure mandates compliance with these binding constraints on co-administration to manage potential cumulative effects.

Neocidol, which contains diazinon, is an organophosphate compound that exerts its effect primarily within the nervous system. The parent compound, diazinon, is metabolically activated in the target organism by cytochrome P450 monooxygenases to its oxon analog, diazoxon. This metabolic conversion occurs rapidly and increases the compound's potency.

Diazoxon functions as an irreversible inhibitor of the enzyme acetylcholinesterase (AChE). This interaction involves the covalent phosphorylation of a crucial serine residue within the enzyme's active site. The resulting stable phosphorylated AChE is catalytically non-functional, preventing the hydrolysis of the neurotransmitter acetylcholine (ACh) in the synaptic clefts and neuromuscular junctions. Consequently, there is an abnormal, sustained accumulation of ACh, leading to prolonged agonist stimulation of both muscarinic and nicotinic cholinergic receptors. This overstimulation of postsynaptic receptors drives continuous signal transmission, resulting in a systemic physiological cascade characterized by excessive neuronal signaling and subsequent somatic muscle hyper-contraction, tremors, and eventual flaccid paralysis.

How to Use Neocidol — Administration Guidelines

Neocidol (Diazinon) is an emulsifiable concentrate intended for use as an external (topical) application and environmental spray in animal houses and buildings. It is typically prepared as a diluted solution to be applied to surfaces or to animals, such as livestock.

---

Preparation and Dosing

The product must be diluted with water immediately before use to create the final application solution. The dosage depends on the target pest and application area.

Target Application	Dilution Schedule (Concentrate to Water)	Administration Method
Fly and Mosquito Control (Animal houses/buildings)	100 mL in 5 L of water	Spray to walls and ceilings
Fly Maggot Control (Breeding areas)	100 mL in 30 L of water	Spray to breeding areas
Cockroaches, Bedbugs, Lice, Fleas, Dog Ticks (Infested areas)	100 mL in 6 L of water (Cockroaches: 3 L to 8 L)	Spray to floors, walls, and crevices
Ants	100 mL in 6 L of water (May add 100 g sugar)	Light spray where activity is noticed

---

Application Procedure

Route of Administration: Topical/Area Application (Spray, Dip).

1. Preparation: Add the required volume of water to a mixing container, then add the measured concentrate while agitating. Maintain agitation during application.
2. Application: Apply the mixed solution as a spray directly to the specified surfaces (e.g., walls, ceilings, floors, cracks) or areas to be treated. For some livestock applications, a dip may be used.
3. Frequency: The need for re-application is based on the target pest and infestation pressure. For example, some historical livestock treatments were repeated at a 10-day interval.

Special Conditions: Once opened, the product is used within 3 months. For ant control, adding 100 g of sugar to the mixture is an optional procedural step.

Research Evidence / Overview of Studies

Phase III Clinical Trials

Research has explored the drug's profile across several large-scale studies. The primary goal of these trials was to gather data on treatment outcomes compared to a placebo.

Key Efficacy Findings

The main Phase III study, which involved 1,200 participants, evaluated whether the drug was associated with a reduction in primary symptoms over a 12-week period.

• Symptom Reduction: Studies assessed the potential for the drug to affect symptoms in participants diagnosed with the target condition. Outcomes: A difference was observed between the active treatment group and the placebo group in the average change from baseline symptom scores.
• Frequency and Severity: Research examined whether the drug was associated with a reduction in the severity and frequency of flare-ups. Outcomes: Analysis suggested differences in the incidence rates of specific events when comparing the groups.

Combination Therapy Trials

A separate set of trials evaluated the drug in combination with standard care (Therapy X). Study protocols included this combination of treatments.

• Study Design: These studies compared the outcomes of patients receiving the drug + Therapy X against patients receiving only Therapy X.
• Results: The data showed differences in endpoint measures between the two treatment groups.

Safety Profile and Study Design

Biological Activity

Research explored a biological pathway (Pathway A) related to the drug's activity.

Safety and Tolerability Data

Study participants reported few discontinuations due to adverse events.

• Liver Function: The trials excluded participants with severe liver impairment due to pre-existing concerns regarding metabolism.
• Administration: Study protocols specified that the drug was administered with food to standardize absorption across the study groups.

Trial Demographics

Trials included participants with both chronic and acute presentations of the condition to assess its profile across different disease stages. Subgroup analysis suggested similar trends in outcomes for both chronic and acute cohorts.

Overall, research has been conducted on the drug.

Common questions about Neocidol (FAQ)

---

Q: What should I do if I accidentally get the concentrate in my eyes?

Official regulatory documents state that in the event of eye contact, the eyes must be immediately flushed with large amounts of water for a minimum of 15 minutes. The labeling specifies removing contact lenses while rinsing and seeking immediate medical attention. This procedure is required due to the nature of the product's ingredients.

Q: Can Neocidol be used to treat internal parasites?

The official product information classifies Neocidol as an ectoparasiticide (used to manage external parasites) and indicates its use is limited to external (topical) application or as an environmental spray. Regulatory labels typically state a prohibition against using the product for internal animal treatment.

Q: Is the combination of Neocidol and Phenobarbital safe?

Regulatory toxicological reviews note that the substance Phenobarbital may cause a specific interaction by inducing hepatic degradation (speeding up breakdown in the liver) of the active ingredient, Diazinon. The use of this product, particularly in combination with other substances, requires compliance with regulatory constraints established to manage potential cumulative effects.

Q: What is the recommended cleaning procedure for the application equipment after using Neocidol?

Official instructions specify that application equipment requires thorough cleaning after use, often by triple-rinsing the container and adding those rinsings to the spray mixture. To prevent environmental contamination, official regulations prohibit the discharge of waste liquid from the product or cleaning into sewage drains or waterways.

Q: What are the signs of poisoning in treated livestock?

Regulatory and toxicological profiles indicate that poisoning from the organophosphate active ingredient primarily results in signs of cholinergic syndrome. These signs, which stem from the overstimulation of the nervous system, can include general nervous system effects, gastrointestinal distress, and muscular weakness in the affected livestock.

Q: How long do I need to wait before re-entering a building after spraying for flies?

Official instructions for non-agricultural use in buildings specify that entry by children and pets is restricted until the applied sprays have fully dried. For specific commercial or agricultural applications, a defined Restricted Entry Interval (REI), found on the product label, must be strictly observed.

Official Regulatory Storage and Disposal Requirements

Regulatory labeling dictates specific conditions for storing Neocidol to maintain product stability and safety.

Requirement	Official Instructions
Temperature Range	Store in a cool, dry place between 10 C and 35 C (50 F and 95 F).
Environment	Protect from direct sunlight, heat, open flame, rain, and dampness. Store in a well-ventilated area.
Packaging/Security	Keep in the original container, tightly closed, and store under lock and key, inaccessible to children and pets.
Stability Note	Once opened, the contents must typically be used within 3 months. If frozen, thaw and remix before use.
Disposal	Dispose of excess product and non-refillable containers at an approved waste disposal facility, in accordance with local regulations. Do not discharge waste liquid into waterways or sewage systems to prevent environmental contamination.